Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 70512-853

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 70512-853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sola Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70512-852-14 120 mg Carton (70512 852 14 120 mg Carton)

Dimethyl Fumarate 120 mg delayed-release capsules label from SOLA Pharmaceuticals, LLC. The label shows the prescription drug name, strength, dosage form, and package size of 14 capsules. Instructions to swallow the capsule whole and storage information are included, along with barcode and manufacturer location in Baton Rouge, LA.*

FDA Label Image

70512-852-14 120 mg Label (70512 852 14 120 mg Label)

Label for Dimethyl Fumarate delayed-release capsules, 120 mg strength, in a 14-capsule package. The label includes instructions to swallow capsules whole and indicates the product is prescription-only. It is manufactured by Sola Pharmaceuticals, LLC, with storage and dosage guidance also noted.*

FDA Label Image

70512-853-carton 240 mg (70512 853 Carton 240 mg)

Packaging label for Dimethyl Fumarate Delayed-Release Capsules 240 mg by SOLA Pharmaceuticals. The label states to swallow the capsule whole and notes Rx only. The package contains 60 capsules. Storage and usage instructions, along with the manufacturer location in Baton Rouge, LA, appear on the label.*

FDA Label Image

70512-853-label 240 mg (70853 853 60 Label 240 mg)

Dimethyl Fumarate 240 mg delayed-release capsules label from SOLA Pharmaceuticals, LLC. The package contains 60 capsules for oral use, labeled as prescription only. Storage instructions include keeping at 20 to 25°C (68 to 77°F) with excursions permitted to 30°C (86°F). Additional directions note to swallow the capsule whole and protect from light.*

FDA Label Image

10 (Dimethyl Fumarate Dr Capsules 1)

Chemical structure diagram of dimethyl fumarate, showing its molecular composition and arrangement of functional groups including ester and alkene moieties.*

FDA Label Image

Figure (Dimethyl Fumarate Dr Capsules 2)

A line graph showing the percentage of subjects with confirmed progression of disability over time in weeks (up to 96 weeks) comparing placebo and Dimethyl Fumarate delayed-release capsules 240 mg BID groups. The y-axis represents the percentage of subjects, and the x-axis is time on study in weeks. The graph shows lower progression in the Dimethyl Fumarate group (16.4%) compared to placebo (27.1%).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.